Equity (Tables)
|
6 Months Ended |
12 Months Ended |
Jun. 30, 2026 |
Dec. 31, 2025 |
| Equity [Line Items] |
|
|
| Schedule of Stock Option Activity |
|
Stock option activity for
the years ended December 31, 2025 and 2024 was as follows:
| | |
Number of Options | | |
Weighted
Average Exercise
Price | |
| Outstanding at January 1, 2024 | |
| 2,844 | | |
$ | 2,980.60 | |
| Granted | |
| 513 | | |
$ | 82.64 | |
| Expired | |
| (733 | ) | |
$ | (5,502.84 | ) |
| Outstanding at December 31, 2024 | |
| 2,624 | | |
$ | 1,708.95 | |
| Granted | |
| 133 | | |
$ | 65.20 | |
| Expired / cancelled / forfeited | |
| (699 | ) | |
$ | (1,749.98 | ) |
| Outstanding at December 31, 2025 | |
| 2,058 | | |
$ | 1,588.61 | |
| Options exercisable at December 31, 2025 | |
| 2,058 | | |
$ | 1,588.61 | |
|
| Schedule of Nonvested Stock Options Granted |
A
summary of the status of the Company’s nonvested stock options granted as of June 30, 2026 and changes during the six months ended
June 30, 2026 is presented below:
| | |
Number of
Options | | |
Weighted
Average
Exercise
Price | |
| Nonvested at January 1, 2026 | |
| - | | |
$ | - | |
| Granted | |
| 107,500 | | |
| 5.64 | |
| Vested | |
| (82,597 | ) | |
| (5.64 | ) |
| Nonvested at June 30, 2026 | |
| 24,903 | | |
$ | 5.64 | |
|
A summary of the status of the Company’s nonvested
stock options granted as of December 31, 2025 and changes during the years ended December 31, 2025 and 2024 is presented below:
| | |
Number of
Options | | |
Weighted
Average
Exercise
Price | |
| Nonvested at January 1, 2024 | |
| 266 | | |
$ | 471.00 | |
| Granted | |
| 513 | | |
$ | 82.64 | |
| Vested | |
| (482 | ) | |
$ | (206.20 | ) |
| Nonvested at December 31, 2024 | |
| 297 | | |
$ | 230.80 | |
| Granted | |
| 133 | | |
$ | 65.20 | |
| Cancelled | |
| (92 | ) | |
$ | (548.00 | ) |
| Vested | |
| (338 | ) | |
$ | (78.40 | ) |
| Nonvested at December 31, 2025 | |
| - | | |
$ | - | |
A summary of the status
of the Company’s nonvested stock warrants issued as of December 31, 2025 and changes during the years ended December 31, 2025 and
2024 was presented below:
| | |
Number of
Warrants | | |
Weighted
Average
Exercise
Price | |
| Nonvested at January 1, 2024 | |
| 761 | | |
$ | 798.00 | |
| Issued | |
| 8,476 | | |
$ | 205.60 | |
| Cancelled | |
| (1,164 | ) | |
$ | (657.00 | ) |
| Vested | |
| (4,073 | ) | |
$ | (242.00 | ) |
| Nonvested at December 31, 2024 | |
| 4,000 | | |
$ | 150.00 | |
| Vested | |
| (4,000 | ) | |
$ | (150.00 | ) |
| Nonvested at December 31, 2025 | |
| - | | |
$ | - | |
|
| Schedule of Stock Warrant Activity |
Stock
warrant activity for the six months ended June 30, 2026 was as follows:
| | |
Number of
Warrants | | |
Weighted
Average
Exercise
Price | |
| Outstanding at January 1, 2026 | |
| 4,787 | | |
$ | 481.17 | |
| Repricing adjustment | |
| 88,822 | | |
$ | 6.60 | |
| Granted | |
| 653,186 | | |
$ | 10.20 | |
| Exercised | |
| (86,678 | ) | |
$ | (6.60 | ) |
| Outstanding at June 30, 2026 | |
| 660,117 | | |
$ | 12.77 | |
| Exercisable at June 30, 2026 | |
| 660,117 | | |
$ | 12.77 | |
|
Stock warrant activity for
the years ended December 31, 2025 and 2024 was as follows:
| | |
Number of
Warrants | | |
Weighted Average Exercise Price | |
| Outstanding at January 1, 2024 | |
| 2,152 | | |
$ | 1,510.60 | |
| Issued | |
| 8,476 | | |
$ | 205.60 | |
| Cancelled (*) | |
| (1,164 | ) | |
$ | (657.00 | ) |
| Exercised | |
| (314 | ) | |
$ | (1,015.40 | ) |
| Outstanding at December 31, 2024 | |
| 9,150 | | |
$ | 427.40 | |
| Exercised | |
| (4,363 | ) | |
$ | (368.19 | ) |
| Outstanding and exercisable at December 31, 2025 | |
| 4,787 | | |
$ | 481.17 | |
| * | Second Warrant, which was issued on May 23, 2023, July 6, 2023, October 9, 2023, and March 7, 2024, was cancelled in June 2024. Second Warrant, which was issued on June 5, 2024, is still outstanding as of December 31, 2025 and 2024. |
|
| Schedule of Number of Pre-Funded Warrants Outstanding |
The
number of pre-funded warrants outstanding as of June 30, 2026 is as follows:
| Description | |
Number
Outstanding | | |
Weighted
Average
Exercise
Price | |
| Pre-funded warrants issued in December 2024 | |
| 7,500 | | |
$ | 0.2 | |
| Pre-funded warrants issued in February 2026 | |
| 167,050 | | |
$ | 0.002 | |
| Outstanding at June 30, 2026 | |
| 174,550 | | |
$ | 0.0105 | |
|
The number of pre-funded
warrants outstanding as of December 31, 2025 is as follows:
| Description | |
Number Outstanding | | |
Weighted
Average
Exercise
Price | |
| Pre-funded warrants issued in December 2024 | |
| 7,500 | | |
$ | 0.2 | |
| Pre-funded warrants issued in July 2025 | |
| 17,715 | | |
$ | 0.002 | |
| Outstanding at December 31, 2025 | |
| 25,215 | | |
$ | 0.0609 | |
|
| Schedule of Pre-Funded Warrant Activity |
A
summary of pre-funded warrant activity during the six months ended June 30, 2026 is as follows:
| | |
Number of
Pre-Funded
Warrants | | |
Weighted
Average
Exercise
Price | |
| Outstanding at January 1, 2026 | |
| 25,215 | | |
$ | 0.0609 | |
| Pre-funded warrants granted | |
| 294,118 | | |
$ | 0.002 | |
| Pre-funded warrants exercised | |
| (144,783 | ) | |
$ | (0.002 | ) |
| Outstanding at June 30, 2026 | |
| 174,550 | | |
$ | 0.0105 | |
|
A summary of pre-funded
warrant activity during the years ended December 31, 2025 and 2024 is as follows:
| | |
Number of Pre-Funded Warrants | | |
Weighted
Average
Exercise
Price | |
| Outstanding at January 1, 2024 | |
| - | | |
$ | - | |
| Pre-funded warrants issued | |
| 7,500 | | |
$ | 0.2 | |
| Outstanding at December 31, 2024 | |
| 7,500 | | |
$ | 0.2 | |
| Pre-funded warrants issued | |
| 17,715 | | |
$ | 0.002 | |
| Outstanding at December 31, 2025 | |
| 25,215 | | |
$ | 0.0609 | |
|
| Schedule of Stock Option Activity |
Stock
option activity for the six months ended June 30, 2026 was as follows:
| | |
Number of
Options | | |
Weighted
Average
Exercise
Price | |
| Outstanding at January 1, 2026 | |
| 2,058 | | |
$ | 1,588.61 | |
| Granted | |
| 107,500 | | |
| 5.64 | |
| Expired | |
| (66 | ) | |
| (889.69 | ) |
| Outstanding at June 30, 2026 | |
| 109,492 | | |
$ | 34.86 | |
| Options exercisable at June 30, 2026 | |
| 84,589 | | |
$ | 43.46 | |
| Options expected to vest | |
| 24,903 | | |
$ | 5.64 | |
|
|
| Options [Member] |
|
|
| Equity [Line Items] |
|
|
| Schedule of Common Stock Issuable Upon Exercise of Options Outstanding |
The
following table summarizes the shares of the Company’s common stock issuable upon exercise of options outstanding at June 30, 2026:
| | Options Outstanding | | | Options Exercisable | | | | Range of
Exercise
Price | | | Number
Outstanding
at June 30,
2026 | | | Weighted Average
Remaining
Contractual Life
(Years) | | | Weighted
Average
Exercise
Price | | | Number
Exercisable at
June 30,
2026 | | | Weighted
Average
Exercise
Price | | | $ | 5.64 – 624.00 | | | | 108,211 | | | | 3.00 | | | $ | 6.21 | | | | 83,308 | | | $ | 6.38 | | | $ | 975.00 – 2,460.00 | | | | 906 | | | | 0.73 | | | $ | 1,597.41 | | | | 906 | | | $ | 1,597.41 | | | $ | 3,090.00 – 4,560.00 | | | | 375 | | | | 3.57 | | | $ | 4,528.52 | | | | 375 | | | $ | 4,528.52 | | | $ | 5.64 – 4,560.00 | | | | 109,492 | | | | 2.98 | | | $ | 34.86 | | | | 84,589 | | | $ | 43.46 | |
|
The following table summarizes
the shares of the Company’s common stock issuable upon exercise of options outstanding at December 31, 2025:
| Options Outstanding | | Options Exercisable | | | Range of Exercise Price | | Number
Outstanding at
December 31,
2025 | | | Weighted
Average
Remaining
Contractual
Life (Years) | | | Weighted
Average
Exercise
Price | | | Number
Exercisable at
December 31,
2025 | | | Weighted
Average
Exercise
Price | | | $58.53 – 624.00 | | | 770 | | | | 2.82 | | | $ | 129.88 | | | | 770 | | | $ | 129.88 | | | $975.00 – 2,460.00 | | | 906 | | | | 1.23 | | | $ | 1,597.41 | | | | 906 | | | $ | 1,597.41 | | | $3,090.00 – 4,560.00 | | | 382 | | | | 4.00 | | | $ | 4,514.43 | | | | 382 | | | $ | 4,514.43 | | | $58.53 – 4,560.00 | | | 2,058 | | | | 2.34 | | | $ | 1,588.61 | | | | 2,058 | | | $ | 1,588.61 | |
|
| Warrants [Member] |
|
|
| Equity [Line Items] |
|
|
| Schedule of Common Stock Issuable Upon Exercise of Options Outstanding |
The
following table summarizes the shares of the Company’s common stock issuable upon exercise of warrants outstanding at June 30,
2026:
| | Warrants Outstanding | | | Warrants Exercisable | | | | Range of
Exercise
Price | | | Number
Outstanding at
June 30,
2026 | | | Weighted Average
Remaining
Contractual Life
(Years) | | | Weighted
Average
Exercise
Price | | | Number
Exercisable at
June 30,
2026 | | | Weighted
Average
Exercise
Price | | | $ | 4.13 – 12.75 | | | | 659,330 | | | | 2.95 | | | $ | 10.21 | | | | 659,330 | | | $ | 10.21 | | | $ | 195.00 – 750.00 | | | | 330 | | | | 2.85 | | | $ | 285.14 | | | | 330 | | | $ | 285.14 | | | $ | 1,350.00 | | | | 44 | | | | 1.93 | | | $ | 1,350.00 | | | | 44 | | | $ | 1,350.00 | | | $ | 3,750.00 | | | | 413 | | | | 0.81 | | | $ | 3,750.00 | | | | 413 | | | $ | 3,750.00 | | | $ | 4.13 – 3,750.00 | | | | 660,117 | | | | 2.95 | | | $ | 12.77 | | | | 660,117 | | | $ | 12.77 | |
|
The following table summarizes the shares of the
Company’s common stock issuable upon exercise of warrants outstanding at December 31, 2025:
| Warrants Outstanding | | Warrants Exercisable | | | Range of Exercise Price | | Number
Outstanding at
December 31,
2025 | | | Weighted Average Remaining Contractual Life (Years) | | | Weighted Average Exercise Price | | | Number
Exercisable
at December 31,
2025 | | | Weighted
Average
Exercise
Price | | | $150.00 – 750.00 | | | 4,330 | | | | 3.42 | | | $ | 160.29 | | | | 4,330 | | | $ | 160.29 | | | $1,350.00 | | | 44 | | | | 2.42 | | | $ | 1,350.00 | | | | 44 | | | $ | 1,350.00 | | | $3,750.00 | | | 413 | | | | 1.30 | | | $ | 3,750.00 | | | | 413 | | | $ | 3,750.00 | | | $150.00 – 3,750.00 | | | 4,787 | | | | 3.23 | | | $ | 481.17 | | | | 4,787 | | | $ | 481.17 | |
|